COMMUNIQUÉS West-GlobeNewswire

-
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
11/04/2025 -
Joule Health & Wellbeing Launches Same-Day Stress Support Services
11/04/2025 -
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
11/04/2025 -
Resolutions of the Annual General Meeting
11/04/2025 -
New Mexico Donor Services Honors Donor Heroes, Families During Donate Life Month
11/04/2025 -
Tennessee Donor Services Honors Donor Heroes, Families During Donate Life Month
11/04/2025 -
Sierra Donor Services Honors Donor Heroes, Families During Donate Life Month
11/04/2025 -
Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis
11/04/2025 -
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
11/04/2025 -
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
11/04/2025 -
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
11/04/2025 -
Scilex Holding Company Announces 1-for-35 Reverse Stock Split
11/04/2025 -
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
11/04/2025 -
FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean
11/04/2025 -
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
11/04/2025 -
Preliminary Results for the Year Ended 31 December 2024
11/04/2025 -
Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
11/04/2025 -
ImPact Biotech Announces New Data Presentations at AUA 2025 Highlighting Safety and Efficacy of Padeliporfin VTP
11/04/2025 -
Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025
11/04/2025
Pages